HEMGENIX - AN OVERVIEW

Range of suitable people: CDEC talked over the uncertainty in the volume of people with reasonably intense to intense hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some patients who are categorised as acquiring gentle or moderate illness may have a intense bleeding phenotype,